Seragen deal

Seragen Inc. (SRGN) SRGN received worldwide rights from Ajinomoto Co. Inc. to interleukin-2 (IL-2) gene patents owned by the Japanese Foundation for Cancer Research and Ajinomoto for use in SRGN's IL...